209 related articles for article (PubMed ID: 22855173)
1. EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.
Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Avirović M; Grahovac B; Jonjić N; Lučin K
Clin Transl Oncol; 2013 Jan; 15(1):65-71. PubMed ID: 22855173
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin expression correlates with nuclear factor-κB activation and apoptosis downregulation in clear cell renal cell carcinoma.
Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Marić I; Spanjol J; Grahovac B; Jonjić N; Lučin K
Pathol Res Pract; 2011 Feb; 207(2):104-10. PubMed ID: 21167650
[TBL] [Abstract][Full Text] [Related]
3. Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors.
Djordjević G; Matusan-Ilijas K; Sinozić E; Damante G; Fabbro D; Grahovac B; Lucin K; Jonjić N
Croat Med J; 2008 Oct; 49(5):608-17. PubMed ID: 18925694
[TBL] [Abstract][Full Text] [Related]
4. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
5. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma.
Huang T; Tian W; Zhou Q; Li J; Jiang Z; Chen J; Ge C; Tian H
Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):988-996. PubMed ID: 34133712
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
Jung M; Lee C; Park JH; Moon KC
Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells.
Ahmed M; Kundu GC
Mol Cancer; 2010 May; 9():101. PubMed ID: 20459645
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
Peri S; Devarajan K; Yang DH; Knudson AG; Balachandran S
PLoS One; 2013; 8(10):e76746. PubMed ID: 24116146
[TBL] [Abstract][Full Text] [Related]
10. Recombinant osteopontin attenuates hyperoxia-induced acute lung injury through inhibiting nuclear factor kappa B and matrix metalloproteinases 2 and 9.
Zhang X; Liu F; Zhu G; Wang Z
Chin Med J (Engl); 2014; 127(23):4025-30. PubMed ID: 25430443
[TBL] [Abstract][Full Text] [Related]
11. CARMA3 Transcriptional Regulation of STMN1 by NF-κB Promotes Renal Cell Carcinoma Proliferation and Invasion.
Shi D; Zhang Z; Kong C
Technol Cancer Res Treat; 2021; 20():15330338211027915. PubMed ID: 34190011
[TBL] [Abstract][Full Text] [Related]
12. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma.
Chen SL; Huang QS; Huang YH; Yang X; Yang MM; He YF; Cao Y; Guan XY; Yun JP
Theranostics; 2020; 10(20):9186-9199. PubMed ID: 32802186
[TBL] [Abstract][Full Text] [Related]
13. Expression of NF-κB and osteopontin of synovial fluid of patients with knee osteoarthritis.
Qin LF; Wang WC; Fang H; Mao XZ; Huang GL; Chen Y; Zhou HD; Shen Y; Qin LH; Peng D
Asian Pac J Trop Med; 2013 May; 6(5):379-82. PubMed ID: 23608377
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase expression profile in clear cell renal cell carcinoma.
Behbahani TE; Thierse C; Baumann C; Holl D; Bastian PJ; von Ruecker A; Müller SC; Ellinger J; Hauser S
World J Urol; 2012 Aug; 30(4):559-65. PubMed ID: 21969129
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cells.
Zhang A; Liu Y; Shen Y; Xu Y; Li X
Med Oncol; 2010 Dec; 27(4):1179-84. PubMed ID: 19921477
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma.
Yushi Q; Li Z; Von Roemeling CA; Doeppler H; Marlow LA; Kim BY; Radisky DC; Storz P; Copland JA; Tun HW
Oncotarget; 2016 May; 7(22):32156-71. PubMed ID: 27050077
[TBL] [Abstract][Full Text] [Related]
17. [Effect of short-hairpin RNA expression vector-mediated osteopontin RNA interference on proliferation and invasion of prostate cancer PC-3 cells].
Liu H; Chen AM; Guo FJ; Liao H; Hu WH; Xie J
Chin J Cancer; 2010 Jan; 29(1):43-51. PubMed ID: 20038310
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway.
Duan J; Jin M; Yang D; Shi J; Gao J; Guo D; Tang H; Zhang S; Qiao B
Bioengineered; 2022 Feb; 13(2):4455-4467. PubMed ID: 35152855
[TBL] [Abstract][Full Text] [Related]
19. MALT1 is required for EGFR-induced NF-κB activation and contributes to EGFR-driven lung cancer progression.
Pan D; Jiang C; Ma Z; Blonska M; You MJ; Lin X
Oncogene; 2016 Feb; 35(7):919-28. PubMed ID: 25982276
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin accelerates chondrocyte proliferation in osteoarthritis rats through the NF-κb signaling pathway.
Sun PF; Kong WK; Liu L; Liu Y; Liu FM; Liu WJ; Yu H; Yang WL; Li GQ; Sun QR
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2836-2842. PubMed ID: 32271401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
